Literature DB >> 7910487

A rating scale for acute drug-induced akathisia: development, reliability, and validity.

P Sachdev1.   

Abstract

This paper describes the process of developing a new rating scale for acute neuroleptic-induced akathisia. Previously reported clinical characteristics of akathisia were used to construct the initial version of the scale. This was administered to 100 consecutively admitted psychiatric patients treated with neuroleptic medication. The scale was then subjected to a reliability analysis, and the number of items reduced. A factor analysis of the ratings supported the decision to rate subjective and objective items separately. The new version of the scale (The Prince Henry Hospital Akathisia Rating Scale) was further standardized in its administration. A preliminary examination of its construct validity was performed by calculating the correlations with the ratings on the analogue and global scales, as well as those of depression, anxiety, and hyperactivity. The new scale was administered to 50 new subjects to examine its interrater reliability and concurrent validity with respect to the Barnes Akathisia Rating Scale.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7910487     DOI: 10.1016/0006-3223(94)91257-2

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  9 in total

1.  Positron emission tomography experience with 2-[¹⁸F]fluoro-3-(2(S)-azetidinylmethoxy)pyridine (2-[¹⁸F]FA) in the living human brain of smokers with paranoid schizophrenia.

Authors:  James Robert Brašić; Nicola Cascella; Anil Kumar; Yun Zhou; John Hilton; Vanessa Raymont; Andrew Crabb; Maria Rita Guevara; Andrew G Horti; Dean Foster Wong
Journal:  Synapse       Date:  2011-12-29       Impact factor: 2.562

2.  Antipsychotic-induced movement disorders: evaluation and treatment.

Authors:  Maju Mathews; Sylvia Gratz; Babatunde Adetunji; Vinu George; Manu Mathews; Biju Basil
Journal:  Psychiatry (Edgmont)       Date:  2005-03

3.  Combining moderators to identify clinical profiles of patients who will, and will not, benefit from aripiprazole augmentation for treatment resistant late-life major depressive disorder.

Authors:  Stephen F Smagula; Meredith L Wallace; Stewart J Anderson; Jordan F Karp; Eric J Lenze; Benoit H Mulsant; Meryl A Butters; Daniel M Blumberger; Breno S Diniz; Francis E Lotrich; Mary Amanda Dew; Charles F Reynolds
Journal:  J Psychiatr Res       Date:  2016-07-07       Impact factor: 4.791

4.  Rate of metoclopramide infusion affects the severity and incidence of akathisia.

Authors:  I Parlak; R Atilla; M Cicek; M Parlak; B Erdur; M Guryay; M Sever; S Karaduman
Journal:  Emerg Med J       Date:  2005-09       Impact factor: 2.740

Review 5.  Research diagnostic criteria for drug-induced akathisia: conceptualization, rationale and proposal.

Authors:  P Sachdev
Journal:  Psychopharmacology (Berl)       Date:  1994-02       Impact factor: 4.530

Review 6.  Antipsychotic-induced akathisia in delirium: A systematic review.

Authors:  Fernando Espi Forcen; Konstantina Matsoukas; Yesne Alici
Journal:  Palliat Support Care       Date:  2015-06-19

7.  Intravenous administration of metoclopramide by 2 min bolus vs 15 min infusion: does it affect the improvement of headache while reducing the side effects?

Authors:  Ismet Parlak; Bulent Erdur; Mine Parlak; Ahmet Ergin; Ibrahim Turkcuer; Onder Tomruk; Cuneyt Ayrik; Nesrin Ergin
Journal:  Postgrad Med J       Date:  2007-10       Impact factor: 2.401

8.  The Tolerability of Mirtazapine Augmentation in Schizophrenic Patients Treated with Risperidone: A Preliminary Randomized Placebo-controlled Trial.

Authors:  Jieun Lee; Sung Joon Cho; Kang Soo Lee; Keunyoung Yook; Ah Young Choe; Sungjae Lee; Borah Kim; Keung-Hyang Kim; Tae Kyou Choi; Sang-Hyuk Lee
Journal:  Clin Psychopharmacol Neurosci       Date:  2011-08-31       Impact factor: 2.582

9.  Remission of Gilles de la Tourette Syndrome after Heat-Induced Dehydration.

Authors:  James Robert Brašić; Zoltan Mari; Alicja Lerner; Vanessa Raymont; Eram Zaidi; Dean F Wong
Journal:  Int J Phys Med Rehabil       Date:  2018-06-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.